Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Abbott LaboratoriesABT |
-$412M |
 |
Ensign GroupENSG |
-$747M |
 |
CG OncologyCGON |
-$434M |
 |
TalkspaceTALK |
$12M |
 |
Inspire Veterinary PartnersIVP |
-$1,000,000 |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| McAlevey Michael R | Nov 5, 2025 | Sell | 3,892 | $473.79 | $1.8M |
| Cuffe Michael S. | Sep 8, 2025 | Sell | 3,836 | $418.84 | $1.6M |
| Foster Jon M | May 13, 2025 | Sell | 15,698 | $369.3248 | $5.8M |
| Berres Jennifer | Feb 14, 2025 | Sell | 4,155 | $322.955 | $1.3M |
| Berres Jennifer | Feb 14, 2025 | Sell | 5,378 | $322.3061 | $1.7M |
| Akdamar Erol R | Nov 14, 2024 | Sell | 2,900 | $353 | $1M |
| Billington Phillip G | Nov 14, 2024 | Sell | 3,897 | $350 | $1.4M |
| Whalen Kathleen M | Nov 14, 2024 | Sell | 1,474 | $357.99 | $530,000 |
| Cuffe Michael S. | Sep 12, 2024 | Sell | 8,358 | $385.42 | $3.2M |
| Whalen Kathleen M | Jul 31, 2024 | Sell | 2,987 | $363.51 | $1.1M |
| Reiner Deborah M | Jul 29, 2024 | Sell | 3,314 | $359.9621 | $1.2M |
| Whalen Kathleen M | Jul 29, 2024 | Sell | 1,864 | $359.92 | $670,000 |
| Wyatt Christopher F. | Jul 29, 2024 | Sell | 4,000 | $360.1956 | $1.4M |
| Torres Kathryn A. | Jul 25, 2024 | Sell | 1,857 | $355.05 | $660,000 |
| Whalen Kathleen M | May 16, 2024 | Sell | 3,204 | $326.3 | $1M |
| Torres Kathryn A. | May 15, 2024 | Sell | 1,863 | $326.1799 | $610,000 |
| Cuffe Michael S. | May 9, 2024 | Sell | 6,311 | $316.8792 | $2M |
| Cohen Jeffrey E. | May 9, 2024 | Sell | 1,650 | $313 | $520,000 |
| Cuffe Michael S. | May 6, 2024 | Sell | 1,600 | $309 | $490,000 |
| Torres Kathryn A. | May 3, 2024 | Sell | 890 | $312 | $280,000 |
| Torres Kathryn A. | May 2, 2024 | Sell | 973 | $312 | $300,000 |
| Wasserman Chad J | Mar 20, 2024 | Sell | 876 | $330.25 | $290,000 |
| Wasserman Chad J | Mar 18, 2024 | Sell | 344 | $321.97 | $110,000 |
| RUTHERFORD BILL B | Feb 6, 2024 | Sell | 6,000 | $310.63 | $1.9M |
| Wyatt Christopher F. | Feb 5, 2024 | Sell | 4,000 | $312.42 | $1.2M |
| Mosier Sammie S | Feb 5, 2024 | Sell | 1,645 | $312 | $510,000 |
| Wasserman Chad J | Feb 2, 2024 | Sell | 652 | $312.0407 | $200,000 |
| Cuffe Michael S. | Jan 31, 2024 | Sell | 3,200 | $306.7918 | $980,000 |
| Torres Kathryn A. | Jan 31, 2024 | Sell | 3,861 | $307 | $1.2M |
FAQ - Insider Transactions
The most recent insider transaction for HCA Healthcare was conducted by McAlevey Michael R, who sold 3,892 shares on November 5, 2025 at a price of $473.79 per share.
Cuffe Michael S. has sold the most HCA stock in the last 2 years, with a total value of $8.3M.
The total value of insider transactions for HCA Healthcare in the last 2 years is negative, amounting to -$35M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for HCA Healthcare have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
